MeSH term | MeSH ID | Detail |
---|---|---|
Edema | D004487 | 152 associated lipids |
Ear Diseases | D004427 | 7 associated lipids |
Glycyrrhetinic acid is a lipid of Prenol Lipids (PR) class. Glycyrrhetinic acid is associated with abnormalities such as Congenital Abnormality, Cortisol 11-beta-ketoreductase deficiency, Hypertensive disease, Mineralocorticoid Excess Syndrome, Apparent and Syndrome. The involved functions are known as Signal, Muscle Contraction, Pressure- physical agent, Agent and Metabolic Inhibition. Glycyrrhetinic acid often locates in Protoplasm, Body tissue, Muscle, Connexon and Extracellular. The associated genes with Glycyrrhetinic acid are SLC33A1 gene, GJB1 gene, RNU1-1 gene, HADHA gene and RNU1-4 gene. The related lipids are Steroids, Saponin, Octanols, Heptanol and amyrin.
To understand associated biological information of Glycyrrhetinic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glycyrrhetinic acid is suspected in Hypertensive disease, Kozlowski Celermajer Tink syndrome, Hypernatremia, Leishmaniasis, Visceral, Congenital Abnormality, Cortisol 11-beta-ketoreductase deficiency and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glycyrrhetinic acid
MeSH term | MeSH ID | Detail |
---|---|---|
Edema | D004487 | 152 associated lipids |
Ear Diseases | D004427 | 7 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Celi FS et al. | Carbenoxolone and hypokalaemic hypertension: case report. | 1988 | Riv Eur Sci Med Farmacol | pmid:3274721 |
Corsi FM et al. | [Hypokalemic myopathy secondary to carbenoxolone ulcer therapy (case report)]. | 1980 Jul-Sep | Riv Neurobiol | pmid:7336082 |
Fujii M | [Pseudoaldosteronism]. | 1997 | Ryoikibetsu Shokogun Shirizu | pmid:9277984 |
Kojima K | [Pseudoaldosteronism]. | 1993 | Ryoikibetsu Shokogun Shirizu | pmid:7757632 |
Young GP et al. | Treatment of reflux oesophagitis with a carbenoxolone/antacid/alginate preparation. A double-blind controlled trial. | 1986 | Scand. J. Gastroenterol. | pmid:3544188 |
Guslandi M et al. | Carbenoxolone maintenance in cimetidine-healed patients. | 1980 | Scand. J. Gastroenterol. | pmid:7433897 |
Parodi MC et al. | Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer. | 1984 | Scand. J. Gastroenterol. Suppl. | pmid:6234649 |
Schenk J et al. | Controlled trial of carbenoxolone sodium vs. cimetidine in duodenal ulcer. | 1980 | Scand. J. Gastroenterol. Suppl. | pmid:7010527 |
Reed PI et al. | The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial. | 1980 | Scand. J. Gastroenterol. Suppl. | pmid:7010528 |
Barbara L et al. | Pirenzepine and carbenozolone in gastric ulcer. Preliminary results of a multicentre double-blind controlled clinical trial. | 1979 | Scand. J. Gastroenterol. Suppl. | pmid:396653 |